跳至主要内容
临床试验/NCT02615418
NCT02615418Unknown不适用

A Novel Non Invasive Brain Stimulation,tDCS Based Treatment for Chronic Low Back Pain (CLBP)-Sourasky Medical Center-Tel Aviv

NIBS NeuroScience Technologies0 个研究点目标入组 60 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
主要终点
Change in CLBP on a 0-10 Numerical Pain Rating Scale (NPRS)

研究概览

简要总结

This trial is designed to preliminary evaluate the efficacy and safety of NIBS system for treatment of chronic low back pain (CLBP) (over 6 months). The trial is of a double blind sham controlled partial crossover design and will involve 2 weekly treatments and evaluations for 6 weeks, with 6 weeks follow-up. The goal of the study is to 1. Asses the CLBP change immediate and long term effect for the trial duration and follow-up. 2. Asses quality of life improvement as measure by sleep quality and questioners. 3. Asses long term neuronal changes or lack thereof in treated and untreated subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 80
  • CLBP as defined by the European guidelines.
  • low back pain first week average NPRS>4.

排除标准

  • Acute low back pain (duration of less than 6 months) first week average NPRS> 4
  • Neurological illness causing structural brain damage (e.g. Stroke, TIA)
  • Psychiatric disease other than mood disorders
  • Current chronic use of medications with pro-epileptic properties
  • Known alcohol dependency
  • Use of alcohol within the previous 24 hours
  • History of loss of consciousness
  • Epilepsy or epilepsy in a first degree relative
  • Medical implants
  • Illicit drug use or within the previous month

结局指标

主要结局

Change in CLBP on a 0-10 Numerical Pain Rating Scale (NPRS)

时间窗: Baseline to week 6 .

次要结局

  • Change From Baseline in Sleep Quality (0-10 Numerical Rating Scale Scores)(Baseline to 6 weeks)
  • Change CLBP quality of life -Roland-Morris questionnaire(Baseline to 6 weeks)

研究者

发起方
NIBS NeuroScience Technologies
申办方类型
Industry
责任方
Sponsor

相似试验

Non Invasive Brain Stimulation Treatment for CLBP | 临床试验